Merck Market Cap 2006-2019 | MRK

Merck market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Merck market cap as of March 31, 2020 is $195.14B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $195.141B $46.840B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $345.705B 15.11
Roche Holding AG (RHHBY) Switzerland $277.843B 0.00
Novartis AG (NVS) Switzerland $188.959B 15.73
Pfizer (PFE) United States $181.075B 11.06
Novo Nordisk (NVO) Denmark $142.554B 24.47
Eli Lilly (LLY) United States $132.760B 22.97
Bristol-Myers Squibb (BMY) United States $125.834B 11.94
AstraZeneca (AZN) United Kingdom $117.205B 25.23
AbbVie (ABBV) United States $112.508B 8.52
Sanofi (SNY) France $109.481B 13.01
GlaxoSmithKline (GSK) United Kingdom $94.546B 11.99
Bayer (BAYRY) Germany $53.976B 7.78
H Lundbeck (HLUYY) Denmark $5.923B 10.29
Innoviva (INVA) United States $1.191B 8.22